Regenerative Medicine Market by Size, Share, Forecasts, & Trends Analysis

Regenerative Market to be Worth $78.53 Billion by 2031

Global Regenerative Market 2022-2029 Meticulous Research , a prominent international market research firm, recently released a report titled Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, PRP, CAR T Cell, Tissue Engineering) Application (Oncology, Cardiovascular, Neurology, Immunology) End User (Hospital, ASC) Global Forecast to 2031. As per the most recent report by Meticulous Research , the regenerative medicine market is anticipated to achieve a value of $78.53 billion by 2031, growing at a compound annual growth rate (CAGR) of 20% between 2024 and 2031. This expansion is attributed to several factors including the growing number of approvals for regenerative medicine, advancements in this field, a rise in the incidence of diseases targeted by these therapies, broader applications of regenerative medicine across various therapy areas, and increased funding for research and development. Nonetheless, challenges such as the high treatment costs and ethical considerations associated with stem cell usage could pose constraints on market growth. Additionally, the growing interest in personalized medicine, escalating demand for organ transplants, and the expanding pipeline of products are anticipated to offer opportunities for market expansion. However, obstacles such as unfavorable reimbursement policies and manufacturing complexities are hindering the market's growth. Key Players The regenerative medicine market is populated by prominent players including Novartis AG (Switzerland), Biogen Inc. (U.S.), AstraZeneca plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Integra Life Sciences (U.S.), Sarepta Therapeutics, Inc. (U.S.), Bayer AG (Germany), Amgen Inc. (U.S.), CORESTEMCHEMON Inc. (South Korea), Smith & Nephew plc (U.K.), GSK plc (U.K.), Takeda Pharmaceutical Company Limited (Japan), Astellas Pharma (Japan), Medtronic plc (Ireland), AbbVie Inc. (U.S.), Bristol Myers Squibb (U.S.), Cook Group Incorporated (U.S.), Pfizer Inc. (U.S.), Merck KGaA (Germany), and Vericel (U.S.). Regenerative Medicine Market: Future Outlook The regenerative medicine market is categorized based on product types such as gene therapy, cell therapy (including stem cell therapy, platelet-rich plasma therapy, and cell- based immunotherapy), and tissue engineering. It is further segmented by applications including cardiovascular diseases, ophthalmic diseases, oncology, neurological diseases, immunology & inflammation, musculoskeletal diseases, dermatological diseases, and other applications. Additionally, the market is segmented by end users into hospitals & clinics and ambulatory surgical centers. The study thoroughly assesses competitors in the industry and provides analysis at both global and regional levels. Among the products covered in this report, the gene therapy sector is forecasted to experience the highest growth rate from 2024 to 2031. This growth is driven by the increasing adoption of gene therapies in the treatment of various diseases like cancer, Page 1 of 4 Meticulous Research| sales@meticulousresearch.com

Global Regenerative Market 2022-2029 immunodeficiency disorders, cystic fibrosis, and diabetes. Gene therapy involves the introduction of new copies of a defective gene or the replacement of a faulty gene entirely. Advancements in genetic engineering technologies, such as CRISPR CAS, are further enhancing the efficacy of gene therapy by enabling precise genome alterations in a shorter timeframe. For example, the U.K. government has approved the use of CRISPR Cas9 gene editing therapy for sickle cell anemia treatment. Additionally, there's a notable focus from manufacturers on developing gene therapy products. According to data from the Alliance for Regenerative Medicine, as of the third quarter of 2023, 556 manufacturers in North America and 209 in Europe were actively involved in the development of gene therapy products. Among the applications covered in this report, in 2024, the oncology segment is expected to dominate the regenerative medicine market. This dominance is driven by several factors, including the significant global burden of cancer, a rising research emphasis on using regenerative medicine for cancer treatment, increasing approvals of regenerative medicine products specifically for oncology applications, a growing number of clinical trials in this area, and the escalating public-private funding aimed at advancing oncology treatments. For example, in March 2023, researchers at the University of California were granted a USD 5.7 million from the California Institute of Regenerative Medicine to support their efforts in advancing stem cell therapy for cancer treatment. Among the end users covered in this report, by 2024, the hospitals & clinics segment is forecasted to hold the majority share of the regenerative medicine market. This dominance can be credited to several factors, including the growing number of both public and private hospitals, the rising incidence of chronic diseases resulting in increased hospital admissions, and the expanding availability of regenerative medicine therapies within hospital settings. Furthermore, the existence of reimbursement policies for regenerative medicine procedures performed at hospitals adds to the segment's significant market share. Geographic Review: The research report examines key geographical regions and offers a thorough analysis of the market across various areas including North America (comprising the U.S. and Canada), Europe (encompassing Germany, France, the U.K., Italy, Spain, Switzerland, Netherlands, Sweden, and the Rest of Europe), Asia-Pacific (including China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), Latin America (comprising Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa. Among the regions analyzed in this report, the Asia-Pacific market is anticipated to demonstrate the most significant growth rate throughout the forecast period. This growth is fueled by proactive government efforts aimed at fostering the development of regenerative medicine and by increased funding for research endeavors. Governments in countries like India, Australia, and South Korea are actively offering research grants to bolster advancements in regenerative medicine, thereby fostering opportunities for market Page 2 of 4 Meticulous Research| sales@meticulousresearch.com

Global Regenerative Market 2022-2029 expansion. As an example, India's Department of Biotechnology allocated a fund of USD 9.35 million over a four-year period from 2019 to 2022 to support research in this domain. Additionally, the affordability of stem cell therapy in nations like India, in contrast to North America and Europe, is drawing medical tourists and stimulating the demand for regenerative medicine. According to reports from Medical Tourism Corporation in India, the cost of stem cell therapy in the country is roughly 25% lower than that in Western nations, rendering it a more cost-effective choice for patients in need of such treatments. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample- report/cp_id=5864 Key questions answered in the report- What are the market segments showing significant growth potential in terms of product, application, end user, and region/country? What was the past global market size of the regenerative medicine market? What are the projected market forecasts and estimations for the period spanning from 2024 to 2031? What are the primary factors propelling, hindering, challenging, offering opportunities, and shaping trends within the regenerative medicine market? Who are the key players in the regenerative medicine market? What does the competitive scenario look like, and who are the leading players in the regenerative medicine market? What are the latest advancements or updates in the regenerative medicine market? What are the various approaches employed by the key players in the regenerative medicine market? What are the trends observed in different geographical regions and which regions or countries show significant growth potential? Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous- research Page 3 of 4 Meticulous Research| sales@meticulousresearch.com

Global Regenerative Market 2022-2029 Page 4 of 4 Meticulous Research| sales@meticulousresearch.com